Literature DB >> 32296952

Updates on Imaging of Liver Tumors.

Arya Haj-Mirzaian1, Ana Kadivar1, Ihab R Kamel1, Atif Zaheer2.   

Abstract

PURPOSE OF REVIEW: We review advances in imaging of liver tumors, by particularly focusing on the utility of novel imaging in diagnosis and management of these lesions. RECENT
FINDINGS: Contrast-enhanced CT and/or MRI are currently utilized for accurate diagnosis of liver tumors, but several ongoing studies are examining the use of other advanced techniques. Novel CT (i.e., dual-energy CT and perfusion CT), MRI (diffusion-weighted imaging, MR elastography, and T1 mapping), and image processing (texture analysis and artificial intelligence-based methods) techniques have emerged and can be used for precise characterization of liver tumors, quantification of treatment responses, and prediction of overall survival rate of patients. Recent advancements in imaging of liver tumors allowed for a precise assessment of tumor features. These evolving technologies can be utilized for applying individualized treatment based on the presence of specific imaging biomarkers.

Entities:  

Keywords:  Artificial intelligence; CT; Contrast-enhanced imaging; Diagnosis; Diffusion-weighted imaging; Dual-energy CT; Hepatocellular carcinoma; Image processing; Liver tumor; MR elastography; MRI; Perfusion CT; T1 mapping; Texture analysis

Year:  2020        PMID: 32296952     DOI: 10.1007/s11912-020-00907-w

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  89 in total

Review 1.  Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma.

Authors:  Tao Jiang; Andrew X Zhu; Dushyant V Sahani
Journal:  J Hepatol       Date:  2012-08-31       Impact factor: 25.083

2.  EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice.

Authors:  Christophe Aubé; Frédéric Oberti; Julie Lonjon; Georges Pageaux; Olivier Seror; Giséle N'Kontchou; Agnes Rode; Sylvie Radenne; Christophe Cassinotto; Julien Vergniol; Ivan Bricault; Vincent Leroy; Maxime Ronot; Laurent Castera; Sophie Michalak; Maxime Esvan; Valérie Vilgrain
Journal:  Liver Int       Date:  2017-04-26       Impact factor: 5.828

Review 3.  Deep learning with convolutional neural network in radiology.

Authors:  Koichiro Yasaka; Hiroyuki Akai; Akira Kunimatsu; Shigeru Kiryu; Osamu Abe
Journal:  Jpn J Radiol       Date:  2018-03-01       Impact factor: 2.374

4.  T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.

Authors:  C Y Chen; J Chen; C C Xia; Z X Huang; B Song
Journal:  J Biol Regul Homeost Agents       Date:  2017 Oct-Dec       Impact factor: 1.711

5.  CT Perfusion for Early Response Evaluation of Radiofrequency Ablation of Focal Liver Lesions: First Experience.

Authors:  Herman P Marquez; Gilbert Puippe; Rishi Philip Mathew; Hatem Alkadhi; Thomas Pfammatter; Michael A Fischer
Journal:  Cardiovasc Intervent Radiol       Date:  2016-11-03       Impact factor: 2.740

6.  T1 mapping on gadoxetic acid-enhanced MR imaging predicts recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  Wen-Tao Wang; Shuo Zhu; Ying Ding; Li Yang; Cai-Zhong Chen; Qing-Hai Ye; Yuan Ji; Meng-Su Zeng; Sheng-Xiang Rao
Journal:  Eur J Radiol       Date:  2018-03-28       Impact factor: 3.528

7.  Rapid switching kVp dual energy CT: Value of reconstructed dual energy CT images and organ dose assessment in multiphasic liver CT exams.

Authors:  Usman Mahmood; Natally Horvat; Joao Vicente Horvat; Davinia Ryan; Yiming Gao; Gabriella Carollo; Rommel DeOcampo; Richard K Do; Seth Katz; Scott Gerst; C Ross Schmidtlein; Lawrence Dauer; Yusuf Erdi; Lorenzo Mannelli
Journal:  Eur J Radiol       Date:  2018-02-19       Impact factor: 3.528

Review 8.  Liver-Directed Therapy for Hepatocellular Carcinoma: An Overview of Techniques, Outcomes, and Posttreatment Imaging Findings.

Authors:  Anne M Covey; Shahid M Hussain
Journal:  AJR Am J Roentgenol       Date:  2017-03-28       Impact factor: 3.959

9.  Does Enhancement or Perfusion on Preprocedure CT Predict Outcomes After Embolization of Hepatocellular Carcinoma?

Authors:  Alessandra Borgheresi; Adrian Gonzalez-Aguirre; Karen T Brown; George I Getrajdman; Joseph P Erinjeri; Anne Covey; Hooman Yarmohammadi; Etay Ziv; Constantinos T Sofocleous; Franz Edward Boas
Journal:  Acad Radiol       Date:  2018-03-27       Impact factor: 3.173

10.  Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.

Authors:  Xiang Li; Chenxia Li; Rong Wang; Juan Ren; Jian Yang; Yuelang Zhang
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

View more
  3 in total

Review 1.  Advanced CT techniques for assessing hepatocellular carcinoma.

Authors:  Yuko Nakamura; Toru Higaki; Yukiko Honda; Fuminari Tatsugami; Chihiro Tani; Wataru Fukumoto; Keigo Narita; Shota Kondo; Motonori Akagi; Kazuo Awai
Journal:  Radiol Med       Date:  2021-05-05       Impact factor: 3.469

2.  Laparoscopic Surgery for a Patient With Multiple Liver Metastases of Unknown Origin Concomitant With Gallbladder Tumor.

Authors:  Yoshihiro Hara; Kensuke Yamamura; Kazuki Matsumura; Eri Oda; Shinichi Akahoshi; Hideaki Yuki; Jun Tomiguchi; Toshihiko Motohara; Hideaki Miyamoto; Yoshihiko Komohara; Toru Beppu
Journal:  In Vivo       Date:  2021 Sep-Oct       Impact factor: 2.406

3.  Comparison of multiphase data from CT perfusion vs clinical 4-phase CT scans with respect to image quality, lesion detection, and LI-RADS classification in HCC patients.

Authors:  A Mohammadi; W Bartholmae; M Woisetschläger
Journal:  Heliyon       Date:  2022-01-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.